CIC
CELL

Carnegie Investment Counsel’s PhenomeX Inc. Common Stock CELL Stock Holding History

Carnegie Investment Counsel’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-23,390
Closed -$1.05M – 489
2021
Q2 		$1.05M Sell
23,390
-1,200
-5% -$55.6K 0.04% 248
2021
Q1 		$1.24M Buy
+24,590
New +$1.68M 0.05% 226

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Carnegie Investment Counsel's CELL Position: Q3 2021 in Review

Carnegie Investment Counsel sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 23,390 shares — an estimated $1.05M sold.

Carnegie Investment Counsel first reported a position in CELL in Q1 2021 and held it in 2 quarters. The position peaked at $1.24M in Q1 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Carnegie Investment Counsel reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Carnegie Investment Counsel sold 23,390 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $1.05M.
  • Carnegie Investment Counsel first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Carnegie Investment Counsel's PhenomeX Inc. Common Stock position peaked at $1.24M in Q1 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Carnegie Investment Counsel's 13F filing for Q3 2021, filed 8 Oct 2021.